FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fresenius Kabi Sensorcaine- MPF Recall

Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0

Fresenius Kabi USA, LLC · Lake Zurich, IL

Risk level
Class II
Reported by FDA
Jun 22, 2016
Recall ID
D-1037-2016
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Sensorcaine- MPF starting Apr 25, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1037-2016 on Jun 22, 2016. Reason: Presence of Particulate Matter: Glass particulate found in sterile injectable product. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Glass particulate found in sterile injectable product

Product description

Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37

Lot numbers, UPCs & expiration codes

Lot #: 6111504, Exp 09/2019

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1037-2016
Classification
Class II
Status
Terminated
Recall initiated
Apr 25, 2016
FDA report date
Jun 22, 2016
Quantity
69225 units
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-1037-2016, exactly as published.

Show all FDA fields
City
Lake Zurich
State
IL
Status
Terminated
Country
United States
Event ID
73935
Address
3 Corporate Dr
Code information
Lot #: 6111504, Exp 09/2019
Postal code
60047-8930
Report date
Jun 22, 2016
Product type
Drugs
Recall number
D-1037-2016
Classification
Class II
Recalling firm
Fresenius Kabi USA, LLC
Product quantity
69225 units
Termination date
Oct 20, 2016
Reason for recall
Presence of Particulate Matter: Glass particulate found in sterile injectable product
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37
Distribution pattern
Nationwide
Recall initiation date
Apr 25, 2016
Initial firm notification
Letter
Center classification date
Jun 16, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1037-2016, published Jun 22, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls